Share Us: Subscribe | Contact

Biblio

Export 3708 results:

Tagged

Author Title Type Year

Filters: First Letter Of Last Name is F [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Receptor, Notch1

G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.

Receptor, Serotonin, 5-HT2A

I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.

Receptors, Glucocorticoid

J. Gräff, Rei, D., Guan, J. - S., Wang, W. - Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., Su, S. C., Samiei, A., Joseph, N., Haggarty, S. J., Delalle, I., and Tsai, L. - H., “An epigenetic blockade of cognitive functions in the neurodegenerating brain.”, Nature, vol. 483, no. 7388, pp. 222-6, 2012.

Receptors, Immunologic

R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., and Zaman, S. H., “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.

R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., and Zaman, S. H., “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.

R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., and Zaman, S. H., “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.

J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., “Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.”, J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.

Receptors, Laminin

E. C. Pinnock, Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. Da Costa, Penny, C., Knackmuss, S., Reusch, U., Little, M., Schatzl, H. M., and Weiss, S. F. T., “LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 645-57, 2016.

Receptors, LDL

H. Xu, Perreau, V. M., Dent, K. A., Bush, A. I., Finkelstein, D. I., and Adlard, P. A., “Iron Regulates Apolipoprotein E Expression and Secretion in Neurons and Astrocytes.”, J Alzheimers Dis, vol. 51, no. 2, pp. 471-87, 2016.

T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.

Recognition (Psychology)

A. J García-Casal, Goñi-Imizcoz, M., M Perea-Bartolomé, V., Soto-Pérez, F., Smith, S. Jane, Calvo-Simal, S., and Franco-Martín, M., “The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.

Recombinant Fusion Proteins

F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.

Recombinant Proteins

K. Talbot, Wang, H. - Y., Kazi, H., Han, L. - Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E., “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.”, J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.

Reference Values

M. Raizes, Elkana, O., Franko, M., Springer, R. Ravona, Segev, S., and Beeri, M. Schnaider, “Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly.”, J Alzheimers Dis, vol. 49, no. 3, pp. 589-92, 2016.

A. Johnen, Frommeyer, J., Modes, F., Wiendl, H., Duning, T., and Lohmann, H., “Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles.”, J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.

H. Xie, Zhang, C., Wang, Y., Huang, S., Cui, W., Yang, W., Koski, L., Xu, X., Li, Y., Zheng, M., He, M., Fu, J., Shi, X., Wang, K., Tang, G., Wang, B., and Huo, Y., “Distinct Patterns of Cognitive Aging Modified by Education Level and Gender among Adults with Limited or No Formal Education: A Normative Study of the Mini-Mental State Examination.”, J Alzheimers Dis, vol. 49, no. 4, pp. 961-9, 2016.

Regenerative Medicine

L. Qiang, Fujita, R., Yamashita, T., Angulo, S., Rhinn, H., Rhee, D., Doege, C., Chau, L., Aubry, L., Vanti, W. B., Moreno, H., and Abeliovich, A., “Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons.”, Cell, vol. 146, no. 3, pp. 359-71, 2011.

Registries

C. Pimouguet, Rizzuto, D., Fastbom, J., Lagergren, M., Fratiglioni, L., and Xu, W., “Influence of Incipient Dementia on Hospitalization for Primary Care Sensitive Conditions: A Population-Based Cohort Study.”, J Alzheimers Dis, vol. 52, no. 1, pp. 213-22, 2016.

C. Pimouguet, Rizzuto, D., Fastbom, J., Lagergren, M., Fratiglioni, L., and Xu, W., “Influence of Incipient Dementia on Hospitalization for Primary Care Sensitive Conditions: A Population-Based Cohort Study.”, J Alzheimers Dis, vol. 52, no. 1, pp. 213-22, 2016.

A. Subic, Cermakova, P., Religa, D., Han, S., von Euler, M., Kåreholt, I., Johnell, K., Fastbom, J., Bognandi, L., Winblad, B., Kramberger, M. G., Eriksdotter, M., and Garcia-Ptacek, S., “Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1119-1128, 2018.

D. Rizzuto, Feldman, A. L., Karlsson, I. K., Aslan, A. K. Dahl, Gatz, M., and Pedersen, N. L., “Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1301-1310, 2018.

F. Nørregaar Pedersen, Stokholm, L., Pouwer, F., Rubin, K. Hass, Peto, T., Frydkjær-Olsen, U., Thykjær, A. Suhr, Andersen, N., Andresen, J., Bek, T., La Cour, M., Heegaard, S., Højlund, K., Kawasaki, R., Hajari, J. Nouri, Kyvik, K. Ohm, Laugesen, C. Schmidt, Schielke, K. Christina, Simó, R., and Grauslund, J., “Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.”, J Alzheimers Dis, vol. 86, no. 1, pp. 451-460, 2022.

G. G. Fillenbaum and Mohs, R., “CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.”, J Alzheimers Dis, vol. 93, no. 1, pp. 1-27, 2023.

Regression Analysis

J. Li, Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., and Zhou, H. D., “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.”, Neurology, vol. 76, no. 17, pp. 1485-91, 2011.

Pages